Synthesis and antiviral activities of hexadecyloxypropyl prodrugs of acyclic nucleoside phosphonates containing guanine or hypoxanthine and a (S)-HPMP or PEE acyclic moiety
Jazyk angličtina Země Francie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
22858222
PubMed Central
PMC7115494
DOI
10.1016/j.ejmech.2012.07.027
PII: S0223-5234(12)00453-9
Knihovny.cz E-zdroje
- MeSH
- antivirové látky chemická syntéza chemie metabolismus farmakologie MeSH
- buněčné linie MeSH
- DNA viry účinky léků MeSH
- guanin analogy a deriváty chemie MeSH
- hypoxanthin chemie MeSH
- hypoxanthiny chemie MeSH
- kyseliny fosforité chemie MeSH
- lidé MeSH
- nukleosidy chemie MeSH
- organofosfonáty chemická syntéza chemie metabolismus farmakologie MeSH
- prekurzory léčiv metabolismus MeSH
- techniky syntetické chemie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antivirové látky MeSH
- guanin MeSH
- hypoxanthin MeSH
- hypoxanthiny MeSH
- kyseliny fosforité MeSH
- nukleosidy MeSH
- organofosfonáty MeSH
- prekurzory léčiv MeSH
Hexadecyloxypropyl esters of acyclic nucleoside phosphonates containing guanine (G) or hypoxanthine (Hx) and a (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] [(S)-HPMP] or 2-(2-phosphonoethoxy)ethyl (PEE) acyclic moiety have been prepared. The activity of the prodrugs was evaluated in vitro against different virus families. Whereas ester derivatives of PEEHx and (S)-HPMPHx were antivirally inactive, monoesters of PEEG, and mono- and diesters of (S)-HPMPG showed pronounced antiviral activity against vaccinia virus and/or herpesviruses. Monoesters of (S)-HPMPG emerged as the most potent and selective derivatives against these DNA viruses. None of the compounds were inhibitory against RNA viruses and retroviruses.
Zobrazit více v PubMed
De Clercq E. Antiviral Res. 2007;75:1. PubMed
Keough D.T., Hocková D., Holý A., Naesens L., Skinner-Adams T.S., de Jersey J., Guddat L. J. Med. Chem. 2009;52:4391. PubMed
de Jersey J., Holy A., Hockova D., Naesens L., Keough D.T., Guddat L.W. Curr. Top. Med. Chem. 2011;11:2085. PubMed
Hostetler K.Y. Antiviral Res. 2009;82:A84. PubMed PMC
D. Hockova, T. Tichy, D.T. Keough, L. Naesens, T.S. Skinner-Adams, J. de Jersey, L. Guddat, unpublished results.
De Clercq E., Sakuma T., Baba M., Pauwels R., Balzarini J., Rosenberg I., Holý A. Antiviral Res. 1987;8:261. PubMed
Valiaeva N., Prichard M.N., Buller R.M., Beadle J.R., Hartline C.B., Keith K.A., Schriewer J., Trahan J., Hostetler K.Y. Antiviral Res. 2009;84:254. PubMed PMC
Starrett J.E., Tortolani D.R., Russell J., Hitchcock M.J.M., Whiterock V., Martin J.C., Mansuri M.M. J. Med. Chem. 1994;37:1857. PubMed
Tichý T., Andrei G., Dračínský M., Holý A., Balzarini J., Snoeck R., Krečmerová M. Bioorg. Med. Chem. 2011;19:3527. PubMed PMC
Jansa P., Holý A., Dračinský M., Baszczyňski O., Česnek M., Janeba Z. Green Chem. 2011;13:882.
Holý A. Synthesis. 1998;29:381.
Vrbkova S., Dračínský M., Holý A. Tetrahedron. 2007;63:11391.
Campagne J.M., Coste J., Jouin P. J. Org. Chem. 1995;60:5214.
Beadle J.R., Hartline C., Aldern K.A., Rodriguez N., Harden E., Kern E.R., Hostetler K.Y. Antimicrob. Agents Chemother. 2002;46:2381. PubMed PMC
Beadle J.R., Wan W.B., Ciesla S.L., Keith K.A., Hartline C., Kern E.R., Hostetler K.Y. J. Med. Chem. 2006;49:2010. PubMed
